Benjamin Hohl, CFO: Enliven Therapeutics ELVN Sell · Filed 24/04/15

Trade details

Type: Insider sale
Amount: $255,983.92
Shares · price: 10,223 sh · $25.04 a share
Held after: 0 sh
Stock: Enliven Therapeutics ELVN
Person: Benjamin HohlCFO
Trade date: 24/04/11
Filed: 24/04/15
Days to filing: 4 days

Sold 100.0% of holdings

Share of holding sold: 100.0%

Enliven Therapeutics trades, last 26 weeks

What else happened in Enliven Therapeutics around then

Filed or reported within 30 days of the trade day · 24/03/12~24/05/11

Benjamin Hohl's recent trades

Benjamin HohlCFO
Planned sale10b5-1 planEnliven Therapeutics
Planned sale10b5-1 plan
Enliven Therapeutics
ELVN
$591.2K
12,036 sh
$591.2K
Filed 09/17
Traded 09/17
Benjamin HohlCFO
Sell10b5-1 planEnliven Therapeutics
Sell10b5-1 plan
Enliven Therapeutics
ELVN
$149.2K
3,401 sh
$149.2K
Filed 06/22
Traded 06/17
Benjamin HohlCFO
Sell10b5-1 planEnliven Therapeutics
Sell10b5-1 plan
Enliven Therapeutics
ELVN
$59K
1,379 sh
$59K
Filed 06/22
Traded 06/17
Benjamin HohlCFO
Sell10b5-1 planEnliven Therapeutics
Sell10b5-1 plan
Enliven Therapeutics
ELVN
$55.4K
1,238 sh
$55.4K
Filed 06/22
Traded 06/17
Benjamin HohlCFO
Planned sale10b5-1 planEnliven Therapeutics
Planned sale10b5-1 plan
Enliven Therapeutics
ELVN
$768.2K
18,054 sh
$768.2K
Filed 06/17
Traded 06/17

Benjamin Hohl, CFO — sold $256K of Enliven Therapeutics ELVN · 100.0% of holdings · 10b5-1 plan | Whalegun